Copyright © 1997 by the European Society of Cardiology.
© 1997 The European Society of Cardiology
Clinical characteristics of chronic heart failure patients with an augmented peripheral chemoreflex
Royal Brompton Hospital and National Heart & Lung Institute, Imperial College School of Medicine London, U.K.
Received 20 September 1996; accepted 25 September 1996.
Correspondence: Dr T. P. Chua, Department of Cardiac Medicine, National Heart & Lung Institute, Dovehouse Street, London SW3 6NP, U.K.
Abstract
AIMS: The peripheral chemoreflex may be augmented in chronic heart failure and may play a role in its pathophysiology including the mediation of exercise hyperpnoea and sympathetic activation. The objective of this study was to characterize the patients with an augmented peripheral chemoreflex.
METHODS AND RESULTS: Peripheral chemoreflex sensitivity was assessed by measuring the ventilatory response to hypoxia using transient inhalations of pure nitrogen in 50 patients with chronic heart failure (age 58·±12·1 (SD) years; radionuclide left ventricular ejection fraction 26·5±13·0%). The peripheral chemoreflex of 12 healthy controls with similar demographic characteristics was 0·272±0·201 1.min–1. %Sao2–1 compared with 0·673±0·4101.min–1.%Sao2–1 (P<0·0001) in the chronic heart failure patients. Using 2 standard deviations above the mean level of the controls' peripheral chemoreflex sensitivity as the upper limit of normal, we defined an augmented chemoreflex as greater than 0·6751.min–1.%Sao2–1 Twenty of the chronic heart failure patients (40%) demonstrated such an augmented peripheral chemoreflex. Compared with patients with peripheral chemoreflex sensitivity within the normal range, they had a reduced peak oxygen consumption during cardiopulmonary exercise (15·1±4·4 vs 18·5±5·8 ml.kg–1.min–1, P=0·02), reduced radionuclide left ventricular ejection fraction (21·8±11·8 vs 29·4±13·1%, P=0·046) and were in a worse New York Heart Association functional class (2·8 vs 2·4 P=0·05). The ventilatory response to exercise, as characterized by the regression slope relating minute ventilation to carbon dioxide output during exercise, was also higher (40·48±9·32 vs 34·54±7·19, P=0·02), consistent with the role of the peripheral chemoreflex in mediating exercise hyperpnoea. There was also an increased proportion of patients with non-sustained ventricular tachycardia in the group with an augmented peripheral chemoreflex (61% vs 21%, chisquared 7·08, P<0·01). No difference was seen in the age, height, weight and lung function measurements of these patients compared with the normal chemoreflex group.
CONCLUSION: An augmented peripheral chemoreflex is a common finding in chronic heart failure patients, one associated with increasing severity and with the exercise hyperpnoea seen in the condition. That there was an excess of patients with non-sustained ventricular tachycardia in the group with an augmented peripheral chemoreflex may be related to the chemoreflex-driven sympathetic stimulation. The peripheral chemoreflex may be important in the pathophysiology of chronic heart failure, both in terms of symptoms and exercise limitation.
Key Words: Chronic heart failure • peripheral chemoreflex
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  Y. Ding, Y.-L. Li, and H. D. Schultz Downregulation of carbon monoxide as well as nitric oxide contributes to peripheral chemoreflex hypersensitivity in heart failure rabbits J Appl Physiol, July 1, 2008; 105(1): 14 - 23. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-L. Li, L. Gao, I. H. Zucker, and H. D. Schultz NADPH oxidase-derived superoxide anion mediates angiotensin II-enhanced carotid body chemoreceptor sensitivity in heart failure rabbits Cardiovasc Res, August 1, 2007; 75(3): 546 - 554. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Di Vanna, A. M. F. W. Braga, M. C. Laterza, L. M. Ueno, M. U. P. B. Rondon, A. C. P. Barretto, H. R. Middlekauff, and C. E. Negrao Blunted muscle vasodilatation during chemoreceptor stimulation in patients with heart failure Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H846 - H852. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Gujic, A. Houssiere, O. Xhaet, J.-F. Argacha, N. Denewet, A. Noseda, P. Jespers, C. Melot, R. Naeije, and P. van de Borne Does Endothelin Play a Role in Chemoreception During Acute Hypoxia in Normal Men? Chest, May 1, 2007; 131(5): 1467 - 1472. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-H. Du and A. F. Chen A "love triangle" elicited by electrochemistry: complex interactions among cardiac sympathetic afferent, chemo-, and baroreflexes J Appl Physiol, January 1, 2007; 102(1): 9 - 10. [Full Text] [PDF]
|
|
|
|
|
|
B. J. Chenuel, C. A. Smith, J. B. Skatrud, K. S. Henderson, and J. A. Dempsey Increased propensity for apnea in response to acute elevations in left atrial pressure during sleep in the dog J Appl Physiol, July 1, 2006; 101(1): 76 - 83. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Dall'Ago, G. R.S. Chiappa, H. Guths, R. Stein, and J. P. Ribeiro Inspiratory Muscle Training in Patients With Heart Failure and Inspiratory Muscle Weakness: A Randomized Trial J. Am. Coll. Cardiol., February 21, 2006; 47(4): 757 - 763. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K K A Witte, S D R Thackray, N P Nikitin, J G F Cleland, and A L Clark Pattern of ventilation during exercise in chronic heart failure Heart, June 1, 2003; 89(6): 610 - 614. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Corra, A. Giordano, E. Bosimini, A. Mezzani, M. Piepoli, A. J. S. Coats, and P. Giannuzzi Oscillatory Ventilation During Exercise in Patients With Chronic Heart Failure* : Clinical Correlates and Prognostic Implications Chest, May 1, 2002; 121(5): 1572 - 1580. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Ponikowski, T. P. Chua, S. D. Anker, D. P. Francis, W. Doehner, W. Banasiak, P. A. Poole-Wilson, M. F. Piepoli, and A. J.S. Coats Peripheral Chemoreceptor Hypersensitivity: An Ominous Sign in Patients With Chronic Heart Failure Circulation, July 31, 2001; 104(5): 544 - 549. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. SOLIN, T. ROEBUCK, D. P. JOHNS, E. HAYDN WALTERS, and M. T. NAUGHTON Peripheral and Central Ventilatory Responses in Central Sleep Apnea with and without Congestive Heart Failure Am. J. Respir. Crit. Care Med., December 1, 2000; 162(6): 2194 - 2200. [Abstract] [Full Text]
|
|
|
|
|
|
D. P. Francis, K. Willson, L. C. Davies, A. J.S. Coats, and M. Piepoli Quantitative General Theory for Periodic Breathing in Chronic Heart Failure and its Clinical Implications Circulation, October 31, 2000; 102(18): 2214 - 2221. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. A. Smith, P. J. Cowburn, M. E. Parker, M. Denvir, S. Puri, K. R. Patel, and J. G. F. Cleland Impaired Pulmonary Diffusion During Exercise in Patients With Chronic Heart Failure Circulation, September 28, 1999; 100(13): 1406 - 1410. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. P. Francis, L. C. Davies, M. Piepoli, M. Rauchhaus, P. Ponikowski, and A. J. S. Coats Origin of Oscillatory Kinetics of Respiratory Gas Exchange in Chronic Heart Failure Circulation, September 7, 1999; 100(10): 1065 - 1070. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Narkiewicz, C. A. Pesek, P. J. H. van de Borne, M. Kato, and V. K. Somers Enhanced Sympathetic and Ventilatory Responses to Central Chemoreflex Activation in Heart Failure Circulation, July 20, 1999; 100(3): 262 - 267. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-Y. Sun, W. Wang, I. H. Zucker, and H. D. Schultz Enhanced peripheral chemoreflex function in conscious rabbits with pacing-induced heart failure J Appl Physiol, April 1, 1999; 86(4): 1264 - 1272. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-Y. Sun, W. Wang, I. H. Zucker, and H. D. Schultz Enhanced activity of carotid body chemoreceptors in rabbits with heart failure: role of nitric oxide J Appl Physiol, April 1, 1999; 86(4): 1273 - 1282. [Abstract] [Full Text] [PDF]
|
|